National/NNP Patent/NNP Development/NNP Corp./NNP said/VBD 0/-NONE- it/PRP plans/VBZ *-1/-NONE- to/TO purchase/VB as/RB many/JJ as/IN 200,000/CD common/JJ shares/NNS of/IN its/PRP$ 81%-controlled/JJ Interferon/NNP Sciences/NNP Inc./NNP unit/NN in/IN periodic/JJ ,/, open-market/JJ purchases/NNS ./.
The/DT 200,000/CD shares/NNS are/VBP about/RB 23/CD %/NN of/IN Interferon/NNP 's/POS common/JJ shares/NNS outstanding/JJ ,/, excluding/VBG National/NNP Patent/NNP 's/POS stake/NN ./.
*-1/-NONE- Noting/VBG the/DT recent/JJ Food/NNP and/CC Drug/NNP Administration/NNP approval/NN of/IN Interferon/NNP 's/POS genital/JJ warts/NNS treatment/NN ,/, National/NNP Patent/NNP said/VBD 0/-NONE- it/PRP believes/VBZ 0/-NONE- Interferon/NNP 's/POS stock/NN is/VBZ undervalued/JJ ./.

